Innovative Medical Technology

Neurotron, Incorporated

   Innovative Medical Technology

                 Established 1981

Neurometer® Painless Electrodiagnostic Sensory Nerve Testing Equipment

 Patient Info

 Research

 Press Releases

 Products

 Exhibitions

 Clinical Apps

 F.A.Q.

 Downloads

 Contact

 Neurometer® tests are painless and can be conducted anywhere on the body - including the most distal cutaneous finger and toe sites for the earliest detection of nerve damage resulting from conditions such as diabetes, carpal tunnel syndrome, spinal injury, sciatica, radiculopathy and nerve regeneration.  This is an improvement over traditional electro-diagnostic and biopsy procedures performed for the past 60 years. Improvements in technology permit measures not effected by skin temperature, edema or electromagnetic interference.  More than 700 peer-reviewed studies document the high sensitivity, specificity and intra-rater and inter-rater reliability of the Neurometer® sensory nerve tests and their advantages over traditional procedures.  No other test provides more information, normative measures and standardized objectivity with painless methodology.

 

  Neurometer® electrodiagnostic sensory nerve conduction threshold (sNCT) testing equipment is unmatched in its ability to painlessly and non-invasively provide a functional evaluation of sensory nerve integrity.  Established normative painless Current Perception Threshold (CPT®) measures the 3 major sub-populations of sensory nerve fibers and permits the determination of neurological dysfunction from hyperesthesia/neuritis through hypoesthesia/neuropathy. The sNCT test reliably and accurately measures the function at any cutaneous site on the body including mucosal surfaces.

 

  Traditional electrodiagnostic nerve tests, such as the sensory nerve conduction velocity (sNCV) examine fewer than 10% of sensory fibers within an isolated segment of a peripheral nerve. The skin punch biopsy provides an invasive measure of sensory innervation. Both tests are insensitive to early stage hyperesthesia and functional complications, and rely on a non-standardized single-blind test procedures. Neurometer® devices quantify the functional integrity of the large myelinated, small myelinated and unmyelinated sensory fibers (>90%) using a standardized double-blind (p<0.006) automated test procedure. These measures are objectively evaluated through computerized comparison to clinically established normative values.

 

Patients demand the highest quality standards and the most up-to-date professional care.

Be comprehensive, proactive and enhance your diagnostic capabilities with

state of the art sensory examinations for your patients.

 

The entire contents of this web site are Copyright Protected 1996-2010, Neurotron, Incorporated

Est. 1981, Baltimore, MD, USA.

rev 01/06/10